China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of lucotinib phosphate cream combined with mucopolysaccharide polysulfonate cream in the treatment of facial non-segmental vitiligo: A prospective, multicenter, real-world study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133993
Registration Time: 2026/10/09
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346645
Published by HT Digital Content Services with permission from Health Daily Digest....